Pieris Pharma (PIRS) Tops Q3 EPS by 1c

November 10, 2016 7:17 AM EST

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

Pieris Pharma (NASDAQ: PIRS) reported Q3 EPS of ($0.14), $0.01 better than the analyst estimate of ($0.15).

Cash and cash equivalents totalled $36.6 million at September 30, 2016, compared to $29.3 million at December 31, 2015. The increase in cash was driven primarily by the $16.5 million gross private placement financing completed in June 2016.

For earnings history and earnings-related data on Pieris Pharma (PIRS) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment